The Latin America, Middle East and Africa Tendonitis Treatment Market should witness market growth of 6.5% CAGR during the forecast period (2022-2028).
If people require more active care, the doctor may administer cortisone injections to the tendon to minimize swelling or advise them to go for an ultrasound to hasten up the healing process. In order to stretch and strengthen the injured tendon as part of treatment and rehabilitation, physical therapy may also be utilized. Surgery can be used to treat tendonitis in more severe situations.
The goal of tendonitis treatment is typically to reduce swelling and manage discomfort. If the disease is severe, tendon repair surgery will be required. Injections of corticosteroids to reduce pain and swelling are one of several therapeutic options, along with platelet-rich plasma (PRP) therapy. In a PRP procedure, the physician will extract a specific volume of the blood and spin it in a centrifuge to create platelets. To hasten the healing process, they will subsequently be injected into the injured tendon.
In the Middle East and North Africa region, childhood and adolescent obesity rates are quickly rising. The UAE boasts a robust healthcare infrastructure as one of the Middle East's most economically advanced and diverse marketplaces. The government of the UAE has made building a top-notch healthcare infrastructure a primary priority, and as a result, the industry has developed and grown tremendously over the past few years.
The Brazil market dominated the LAMEA Tendonitis Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,888.6 million by 2028. The Argentina market is experiencing a CAGR of 7% during (2022-2028). Additionally, The UAE market would display a CAGR of 6.2% during (2022-2028).
Based on Type, the market is segmented into Therapy and Surgery. Based on Therapy Type, the market is segmented into Physical Therapy, Hot & Cold Therapy and Shockwave Therapy. Based on Condition, the market is segmented into Achilles Tendonitis, Jumper’s Knee, Tennis Elbow, Pitcher’s Elbow, Swimmer’s Shoulder and Golfer’s Elbow. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Merck & Co., Inc., Bayer AG, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Abbott Laboratories, Pfizer, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., and Almatica Pharma, Inc.
If people require more active care, the doctor may administer cortisone injections to the tendon to minimize swelling or advise them to go for an ultrasound to hasten up the healing process. In order to stretch and strengthen the injured tendon as part of treatment and rehabilitation, physical therapy may also be utilized. Surgery can be used to treat tendonitis in more severe situations.
The goal of tendonitis treatment is typically to reduce swelling and manage discomfort. If the disease is severe, tendon repair surgery will be required. Injections of corticosteroids to reduce pain and swelling are one of several therapeutic options, along with platelet-rich plasma (PRP) therapy. In a PRP procedure, the physician will extract a specific volume of the blood and spin it in a centrifuge to create platelets. To hasten the healing process, they will subsequently be injected into the injured tendon.
In the Middle East and North Africa region, childhood and adolescent obesity rates are quickly rising. The UAE boasts a robust healthcare infrastructure as one of the Middle East's most economically advanced and diverse marketplaces. The government of the UAE has made building a top-notch healthcare infrastructure a primary priority, and as a result, the industry has developed and grown tremendously over the past few years.
The Brazil market dominated the LAMEA Tendonitis Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,888.6 million by 2028. The Argentina market is experiencing a CAGR of 7% during (2022-2028). Additionally, The UAE market would display a CAGR of 6.2% during (2022-2028).
Based on Type, the market is segmented into Therapy and Surgery. Based on Therapy Type, the market is segmented into Physical Therapy, Hot & Cold Therapy and Shockwave Therapy. Based on Condition, the market is segmented into Achilles Tendonitis, Jumper’s Knee, Tennis Elbow, Pitcher’s Elbow, Swimmer’s Shoulder and Golfer’s Elbow. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Merck & Co., Inc., Bayer AG, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Abbott Laboratories, Pfizer, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., and Almatica Pharma, Inc.
Scope of the Study
By Type
- Therapy
- Physical Therapy
- Hot & Cold Therapy
- Shockwave Therapy
- Surgery
By Condition
- Achilles Tendonitis
- Jumper’s Knee
- Tennis Elbow
- Pitcher’s Elbow
- Swimmer’s Shoulder
- Golfer’s Elbow
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Merck & Co., Inc.
- Bayer AG
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Abbott Laboratories
- Pfizer, Inc.
- GlaxoSmithKline PLC
- Teva Pharmaceuticals Industries Ltd.
- Almatica Pharma, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. LAMEA Tendonitis Treatment Market by Type
Chapter 5. LAMEA Tendonitis Treatment Market by Condition
Chapter 6. LAMEA Tendonitis Treatment Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Merck & Co., Inc.
- Bayer AG
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Abbott Laboratories
- Pfizer, Inc.
- GlaxoSmithKline PLC
- Teva Pharmaceuticals Industries Ltd.
- Almatica Pharma, Inc.
Methodology
LOADING...
